Diabetes Mayo Clinic Vaccines 
Pharmacy Times
JUNE 24, 2025
In an interview with Pharmacy Times at the 2025 Oncology Pharmacists Connect (OPC) meeting, Scott Soefje, PharmD, MBA, BCOP, director of pharmacy at Mayo Clinic, focused on the evolving role of pharmacists in healthcare, highlighting their increasing presence in outpatient settings to enhance efficiency and patient care.
Pharmacy Times
JUNE 16, 2025
Mayo Clinic. RAD 2025: Long-term data on Nemluvio® (nemolizumab) demonstrate its favorable safety profile and sustained and increased improvements in itch and skin lesions in patients with atopic dermatitis up to two years. News release. June 6, 2025. Accessed June 16, 2025. Atopic Dermatitis. News release. May 15, 2024. Ferruggia K.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
JULY 25, 2025
Mayo Clinic. Mayo Clinic. Thrombocytopenia (low platelet count). May 13, 2025. Accessed July 25, 2025. Advances in management of pediatric chronic immune thrombocytopenia: a narrative review. J Yeungnam Med Sci. January 9, 2023. doi: 10.12701/jyms.2022.00745 2022.00745 5. Avatrombopag (oral route). July 1, 2025.
Pharmacy Times
JUNE 20, 2025
Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)
Pharmacy Times
JUNE 23, 2025
This act…allowed a pathway for manufacturers to create a ‘copy’ of a licensed patent product to make it cheaper and more discounted,” Soefje, director of pharmacy cancer care services and associate professor of pharmacy at Mayo Clinic in Rochester, Minnesota, said at the HOPA conference.
Pharmacy Times
JULY 7, 2025
Risk factors that could increase the development of HCC, along with chronic liver conditions, include older age, excess fat in the liver, diabetes, obesity, exposure to aflatoxins, excessive alcohol consumption, and cigarette smoking. 2 "The expanded indication makes SIR-Spheres ® the only Y-90 treatment approved in the U.S.
Pharmacy Times
JUNE 9, 2025
Tichy, PharmD, MBA, vice chair of pharmacy formulary for Mayo Clinic, explained. Still, confusion remains over the role of pharmacy and therapeutics (P&T) committees in this process. This governance issue is a very hot topic,” Eric M.
Expert insights. Personalized for you.
26 
Let's personalize your content